文献速递胃肠外科

经口内镜下肌切开术是治疗贲门失弛缓症合并食管裂孔疝的有效方法

Peroral endoscopic myotomy is an effective treatment for achalasia combined with hiatal hernia.
PubMed 文献 · Surg Endosc · 2024-06-27

该回顾性研究纳入2016年1月至2022年12月间2136例贲门失弛缓症患者,其中56/1564(3.6%)合并食管裂孔疝并接受经口内镜下肌切开术(POEM)。与匹配的无疝对照组相比,研究组在黏膜损伤、气胸、胸腔积液、主要不良事件及1至3年随访的临床成功率、临床反流和质子泵抑制剂使用方面均无显著差异。结论认为POEM对贲门失弛缓症合并食管裂孔疝安全有效。

要点

  • 贲门失弛缓症患者中食管裂孔疝检出率为3.6%(56/1564)。
  • 1至3年随访中,研究组与对照组的临床成功率、反流及PPI使用均无显著差异。

核心结论

  • POEM是治疗贲门失弛缓症合并食管裂孔疝的安全有效方法。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2022年12月间2136例贲门失弛缓症患者,将合并食管裂孔疝者设为研究组,匹配无疝的贲门失弛缓症患者为对照组,比较基线、操作相关不良事件及随访资料。

主要发现

  • 食管裂孔疝在贲门失弛缓症患者中的检出率为3.6%(56/1564),所有合并疝者均成功完成POEM。
  • 研究组与对照组的黏膜损伤发生率分别为12.5%与16.1%(P=0.589),气胸为3.6%与1.8%(P=1.000),胸腔积液为8.9%与12.5%(P=0.541),主要不良事件均为1.8%(P=1.000)。
  • 1年随访时,研究组与对照组的临床成功率分别为96.4%与92.9%(P=0.679),临床反流为25.0%与19.6%(P=0.496),质子泵抑制剂使用为17.9%与16.1%(P=0.801)。
  • 2年随访时,临床成功率分别为93.6%与94.0%(P=1.000),临床反流为31.9%与26.0%(P=0.521),质子泵抑制剂使用为29.8%与24.0%(P=0.520)。
  • 3年随访时,临床成功率分别为86.5%与91.4%(P=0.711),临床反流为35.1%与31.4%(P=0.739),质子泵抑制剂使用为32.4%与25.7%(P=0.531)。

临床怎么用

  • 原文结论认为POEM是治疗贲门失弛缓症合并食管裂孔疝的安全有效方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the feasibility of peroral endoscopic myotomy (POEM) in patients with achalasia and hiatal hernia. MATERIALS AND METHODS: We performed a retrospective review of 2136 patients with achalasia between January 2016 and December 2022. Patients with achalasia and hiatal hernia were assigned into study group, and matched patients with achalasia but no hiatal hernia were assigned into control group. The preoperative baseline information, procedure-related adverse events (AEs) and follow-up data were compared between the two groups. RESULTS: Hiatal hernia was identified in 56/1564 (3.6%) patients with achalasia. All of these patients underwent POEM with success. The preoperative baseline characteristics were similar between the study and control group. The study group presented with a similar rate of mucosal injury (12.5% vs 16.1, P = 0.589), pneumothorax (3.6% vs 1.8%, P = 1.000), pleural effusion (8.9% vs 12.5%, P = 0.541) and major AEs (1.8% vs 1.8%, P = 1.000) compared with the control group. As for the follow-up data, no significant differences were observed in clinical success (96.4% vs 92.9%, P = 0.679; 93.6% vs 94.0%, P = 1.000; 86.5% vs 91.4%, P = 0.711) clinical reflux (25.0% vs 19.6%, P = 0.496; 31.9% vs 26.0%, P = 0.521; 35.1% vs 31.4%, P = 0.739) and proton pump inhibitor usage (17.9% vs 16.1%, P = 0.801; 29.8% vs 24.0%, P = 0.520; 32.4% vs 25.7%, P = 0.531) between the study group and control group at 1-year, 2-year and 3-year follow-ups. CONCLUSIONS: POEM is a safe and effective treatment for achalasia combined with hiatal hernia.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Xu P, Liu Z, Zhang J, et al. Peroral endoscopic myotomy is an effective treatment for achalasia combined with hiatal hernia. Surg Endosc. 2024. PMID: 38937313. doi:10.1007/s00464-024-10948-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。